[Experiences with ambulatory intermittent cytostatic treatment of bronchial cancer].
D000553:Ambulatory Care; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001984:Bronchial Neoplasms / Q000188:drug therapy* / Q000401:mortality; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality; D010166:Palliative Care; D011379:Prognosis; D011736:Pyridoxine / Q000627:therapeutic use*; D014228:Triaziquone / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D014228:Triaziquone; D011736:Pyridoxine
Expériences avec le traitement cytostatique amublatoire intermittent du cancer bronchique.